DUBLIN, Feb. 17, 2020 /PRNewswire/ -- The "Stem Cell Manufacturing Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

The Stem Cell Manufacturing market is projected to grow with a CAGR of nearly 3.3% over the forecast period.

The major factors attributing to the growth of the market include the technological advancements in stem cell manufacturing and preservation and growing public awareness about the therapeutic potency of stem cell products.

According to California Institute for Regenerative Medicine, for the millions of people around the world who suffer from incurable diseases and injury, Stem Cell Awareness Day, October 11th is a day to celebrate the scientific advances made to-date. Research and academic institutions and educators are encouraged to participate by hosting public talks and other activities and events in their community. Furthermore, the growing growing public-private investments and funding in stem cell-based research is boosting the market growth. However, the gaining popularity of alternative procedures is the major drawback of market growth.

Stem Cell Banking Segment is the Fastest Growing Segment in the Stem Cell Manufacturing Market.

Stem cell bank is a provision that stores stem cells developed from amniotic fluid for future use. Stem cell samples in private banks are stored specifically for use by the individual person from whom such cells have been collected and the banking costs are paid the person. The sample can later be recovered only by that individual and for the use by such individual or, in many cases, by her or his first-degree blood relatives.

The major factor driving the growth of the segment is the increasing public demand for cord blood stem cell banking and rising awareness regarding the prospective advantages of stem cell preservation. Furthermore, stem cells have been proven to treat approximately 80 diseases and disorders including hematopoietic disorders, immunodeficiency diseases, metabolic disorders, etc. With the continued increase in per capita disposable revenue across developing countries and an expected decrease in product costs associated with stem cell therapies, increasing public awareness and the adoption of stem cell therapies, are the reasons driving the segment growth.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to the factors such as the presence of key players, high concentration of stem cell research in the region, mounting public-private funding and grants to support the clinical evaluation of stem cells for various applications, robust research infrastructure, and raising public awareness on the therapeutic potency of stem cells. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth.

Competitive Landscape

The Stem Cell Manufacturing market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Anterogen, Becton, Dickinson and Company, Cellular Dynamics (Fujifilm Holdings Corporation), Lonza Group, Stemcell Technologies, Medipost, Merck Group, Osiris Therapeutics, Pluristem Therapeutics, Bio-Rad Laboratories.

Key Topics Covered

1 INTRODUCTION1.1 Study Deliverables1.2 Study Assumptions1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS4.1 Market Overview4.2 Market Drivers4.2.1 Technological Advancements in Stem Cell Manufacturing and Preservation4.2.2 Growing Public Awareness About the Therapeutic Potency of Stem Cell Products4.2.3 Growing Public-Private Investments and Funding in Stem Cell-Based Research4.3 Market Restraints4.3.1 High Operational Costs Associated With Stem Cell Manufacturing and Banking4.4 Porter's Five Force Analysis

5 MARKET SEGMENTATION5.1 By Product5.1.1 Culture Media5.1.2 Consumables5.1.3 Instruments5.1.4 Stem Cell Lines5.2 By Application5.2.1 Stem Cell Therapy5.2.2 Drug Discovery and Development5.2.3 Stem Cell Banking5.2.4 Others5.3 By End-User5.3.1 Pharmaceutical and Biotechnology Companies5.3.2 Cell Banks and Tissue Banks5.3.3 Others5.4 Geography5.4.1 North America5.4.2 Europe5.4.3 Asia-Pacific5.4.4 Middle-East and Africa5.4.5 South America

6 COMPETITIVE LANDSCAPE6.1 Company Profiles6.1.1 Anterogen6.1.2 Becton, Dickinson and Company6.1.3 Cellular Dynamics (Fujifilm Holdings Corporation)6.1.4 Lonza Group6.1.5 Stemcell Technologies6.1.6 Medipost6.1.7 Merck Group6.1.8 Osiris Therapeutics6.1.9 Pluristem Therapeutics6.1.10 Bio-Rad Laboratories

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/wqnf8z

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/stem-cell-manufacturing-in-stem-cell-therapy-drug-discovery--development-stem-cell-banking-and-more-2020-2025-301006076.html

SOURCE Research and Markets

Read the original:
Stem Cell Manufacturing in Stem Cell Therapy, Drug Discovery & Development, Stem Cell Banking, and More (2020-2025) - P&T Community